Let’s start up with the current stock price of ADMA Biologics Inc. (ADMA), which is $2.95 to be very precise. The Stock rose vividly during the last session to $2.99 after opening rate of $2.95 while the lowest price it went was recorded $2.79 before closing at $2.74.
Recently in News on February 1, 2021, ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN. ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it has received U.S. Food and Drug Administration (“FDA”) approval for its ADMA BioCenters plasma collection facility located in Knoxville, Tennessee. This plasma collection facility commenced operations and initiated source plasma collection in the third quarter of 2020, and with today’s approval, it is now FDA licensed to collect and introduce into interstate commerce human source plasma for further manufacturing in the U.S. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
ADMA Biologics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.99 on 02/09/21, with the lowest value was $1.98 for the same time period, recorded on 01/04/21.
ADMA Biologics Inc. (ADMA) full year performance was -14.74%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ADMA Biologics Inc. shares are logging -29.76% during the 52-week period from high price, and 103.45% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.45 and $4.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7571984 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ADMA Biologics Inc. (ADMA) recorded performance in the market was 51.28%, having the revenues showcasing 54.45% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 285.35M, as it employees total of 313 workers.
Analysts verdict on ADMA Biologics Inc. (ADMA)
During the last month, 5 analysts gave the ADMA Biologics Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.18, with a change in the price was noted +0.55. In a similar fashion, ADMA Biologics Inc. posted a movement of +22.92% for the period of last 100 days, recording 3,436,042 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ADMA is recording 1.36 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.36.
ADMA Biologics Inc. (ADMA): Technical Analysis
Raw Stochastic average of ADMA Biologics Inc. in the period of last 50 days is set at 96.49%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 95.74%. In the last 20 days, the company’s Stochastic %K was 80.54% and its Stochastic %D was recorded 74.73%.
Let’s take a glance in the erstwhile performances of ADMA Biologics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 51.28%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -2.96%, alongside a downfall of -14.74% for the period of the last 12 months. The shares increased approximately by 20.90% in the 7-day charts and went down by 37.85% in the period of the last 30 days. Common stock shares were driven by 54.45% during last recorded quarter.